Skip to main content
Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
200.40
-1.64 (-0.81%)
Apr 16, 2025, 4:00 PM EDT - Market closed

BDX Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Medical
10.07B 9.79B 9.67B 9.58B 9.50B 8.79B 8.54B 8.60B
Medical Growth
6.02% 11.45% 13.17% 11.40% 7.48% -7.88% -12.12% -10.58%
Life Sciences
5.19B 5.18B 5.15B 5.12B 5.13B 5.09B 5.17B 5.38B
Life Sciences Growth
1.13% 1.81% -0.48% -4.90% -7.75% -12.38% -12.81% -10.79%
Interventional
4.98B 4.92B 4.90B 4.80B 4.74B 4.63B 4.55B 4.48B
Interventional Growth
5.15% 6.35% 7.64% 7.08% 6.09% 4.28% 3.97% 4.65%
Other
- -67.00M - - - - - -

Revenue by Geography
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
United States
11.66B 11.43B 11.31B 11.13B 11.11B 10.65B 10.53B 10.60B
United States Growth
4.95% 7.24% 7.41% 5.03% 3.65% -4.07% -4.64% -0.87%
International
8.52B 8.40B 8.41B 8.36B 8.26B 7.85B 7.75B 7.86B
International Growth
3.11% 7.00% 8.59% 6.34% 1.35% -9.49% -13.89% -14.89%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.